SAFEGUARD SCIENTIFICS INC (SFE)

US7864493066 - Common Stock

0.455  -0.2 (-30.21%)

After market: 0.56 +0.11 (+23.08%)

Fundamental Rating

2

Taking everything into account, SFE scores 2 out of 10 in our fundamental rating. SFE was compared to 210 industry peers in the Capital Markets industry. While SFE has a great health rating, there are worries on its profitability. SFE has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

In the past year SFE has reported negative net income.
In the past year SFE has reported a negative cash flow from operations.
In multiple years SFE reported negative net income over the last 5 years.
In the past 5 years SFE always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -32.10%, SFE is not doing good in the industry: 98.53% of the companies in the same industry are doing better.
The Return On Equity of SFE (-34.78%) is worse than 95.59% of its industry peers.
Industry RankSector Rank
ROA -32.1%
ROE -34.78%
ROIC N/A
ROA(3y)-14.12%
ROA(5y)-0.46%
ROE(3y)-15.87%
ROE(5y)-3.44%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SFE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

SFE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SFE has less shares outstanding
SFE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

SFE has an Altman-Z score of -29.56. This is a bad value and indicates that SFE is not financially healthy and even has some risk of bankruptcy.
SFE has a Altman-Z score of -29.56. This is amonst the worse of the industry: SFE underperforms 95.10% of its industry peers.
There is no outstanding debt for SFE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -29.56
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

SFE has a Current Ratio of 10.19. This indicates that SFE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 10.19, SFE belongs to the top of the industry, outperforming 94.61% of the companies in the same industry.
A Quick Ratio of 10.19 indicates that SFE has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 10.19, SFE belongs to the best of the industry, outperforming 94.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.19
Quick Ratio 10.19

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.19% over the past year.
EPS 1Y (TTM)40.19%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q131.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SFE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SFE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SAFEGUARD SCIENTIFICS INC

NASDAQ:SFE (2/9/2024, 7:07:22 PM)

After market: 0.56 +0.11 (+23.08%)

0.455

-0.2 (-30.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.54M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.1%
ROE -34.78%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 10.19
Quick Ratio 10.19
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)40.19%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y